Pr Stéphane Oudard
- Specialty
- Oncologist, urology expert
- Title
- Head of service
- Hospital
- Hôpital Européen Georges Pompidou (Paris)
- Latest articles
-
- Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study. (Nov 11, 2025)
- PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: Rationale, Mechanisms, and Clinical Applications. (Nov 10, 2025)
- The CD70-CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target. (Jul 15, 2025)
- Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial. (Jul 1, 2025)
- Fake It till You Predict It: Data Augmentation Strategies to Detect Initiation and Termination of Oncology Treatment. (May 15, 2025)